If dizziness persists, consult your healthcare provider
You may be a good candidate for Wegovy if you have the following: Body mass index (BMI) over 30 BMI over 27, plus a weight-related health condition such as high blood pressure, diabetes, or elevated lipids
Short for Beyond-Use Date , the BUD plays a critical role in ensuring your medication remains stable, safe, and effective throughout its intended use
Nutritional Framework: Adopt a balanced, nutrient-dense eating pattern that emphasises whole foods
The detailed molecular regulation of the autophagy system in cells via GLP-1 receptor signaling requires further investigation
Clinical Trial Results: What the Data Shows Semaglutide has been evaluated in the STEP (Semaglutide Treatment Effect in People with obesity) trial program, which included four major studies of semaglutide 2.4 mg weekly across different patient populations, including adults with obesity, adults with type 2 diabetes, and adults receiving intensive behavioral support alongside the medication